Dr BENDER Laura

Fiche personne


coordonnées

ICANS | Institut cancérologie Strasbourg Europe
17 rue Albert Calmette
BP 23025
67033 STRASBOURG

03 68 76 66 66

l.bender@icans.eu

Territoire

Alsace

Statut

Hospitalier

équipes/plateformes

Equipe Oncologie médicale

Publications


Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma.

Benistant L, Reita D, Schenck M, Castelain V, Cebula H, Lhermitte B, Bender L

Ann Clin Transl Neurol. 2024 10 23;:

Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer: Results from the phase 1a/1b EMBER study.

Yonemori K, Boni V, Min KG, Meniawy TM, Lombard J, Kaufman PA, Richardson DL, Bender L, Okera M, Matsumoto K, Giridhar KV, García-Sáenz JA, Prenen H, de Speville Uribe BD, Dizon DS, Garcia-Corbacho J, Van Nieuwenhuysen E, Li Y, Estrem ST, Nguyen B, Bacchion F, Ismail-Khan R, Jhaveri K, Banda K

Gynecol Oncol. 2024 10 22;191:172-181

Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature.

Pușcașu A, Moinard-Butot F, Nannini S, Fischbach C, Schott R, Bender L

Cancers (Basel). 2024 09 8;16(17):

Voir plus